Roy Abraham, MD, trained under the inventors of the implant in the United Kingdom, which is one reason why he is interested in the study aiming to determine whether the cementless partial knee replacement has good or better outcomes than the traditional PKR procedure.
The study is expected to span a four-year period and include 383 patients. The cementless implant has a porous surface that allows for bone growth, as well as two pegs.
Related Articles on Orthopedic Surgery:
35 Years and Counting: Q&A With Dr. Kieth Berend on the Oxford Partial Knee Replacement
New Hip Implants Don't Show Improvement Over Old Models
Global Orthopedic Implant Market to Reach $46.5B by 2017
Miller Orthopaedic Affiliates in Iowa Participates in Cementless Partial Knee Replacement FDA TrialWritten by Laura Miller | December 02, 2011
An orthopedic surgeon with Miller Orthopaedic Affiliates in Council Bluffs, Iowa, is currently participating in an FDA trial of the Oxford Cementless Partial Knee Replacement from Biomet, according to a report from The Daily Nonpareil.
© Copyright ASC COMMUNICATIONS 2011. Interested in LINKING to or REPRINTING this content? View our policies here.